Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

The Oral Language Assessment was developed by the Public Service Commission of Canada (PSC) to help departments and agencies staff bilingual positions. It assesses your ability to communicate orally ...

The brand has been around in one form or another since 1949, and diehard sneakerheads will remind you that it wasn’t that long ago that the Gel-Lyte III was a bona fide collaborative grail.

Wedding, hectic schedule, vacation, or simply because you like the look—there comes a time when you just need the long-wear of the best gel nail polish. “Gel polish is basically your mani’s ...

If you’re feeling a sense of déjà vu as we prepare to say goodbye to the Conner family, it’s not a surprise given we’ve been here before more than once. The first time was in 1997 when ...

Compounded semaglutide and Ozempic should contain the same active ingredient: semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. A key difference between compounded ...

Summary: A new study has identified a strong link between oral microbiota and autism spectrum disorder (ASD), revealing 11 bacterial species with potential as biomarkers. By analyzing oral samples ...

A once-daily oral PCSK9 inhibitor reduced LDL in patients with hypercholesterolemia. Safety and tolerability profiles were favorable, according to investigators. CHICAGO — In a phase 2b study ...

Drucker and three co-winners made discoveries about glucagon-like peptide-1 in their labs. The other recipient of the award, Lotte Bjerre Knudsen, who works for Novo Nordisk, led the way in ...

Drucker and three co-winners made discoveries about glucagon-like peptide-1 in their labs. The other recipient of the award, Lotte Bjerre Knudsen, who works for Novo Nordisk, led the way in ...

Rybelsus (semaglutide) is an oral medication used in combination with ... Rybelsus belongs to a group of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. These medications: slow ...

The 2025 Breakthrough Prize in Life Sciences has been awarded to five scientists for the discovery and characterization of the hormone glucagon-like peptide-1, or GLP-1 — findings that subsequently ...